Shockwave Medical (SWAV) tripled Wall Street’s fourth-quarter profitability expectations, leading SWAV stock to surge on Friday. X The company makes lithotripsy tools to “crack” hardened calcium in the arteries. During the December quarter, Shockwave earned $3.71 per share, blowing away projections for $1.01, according to FactSet. Sales also beat views …
Read More »Biotech Growth Stock Boosted By FDA Approval For Multiple Sclerosis Treatment
Biotech growth stock TG Therapeutics (TGTX) got FDA approval for its multiple sclerosis drug in December, setting off a strong advance that’s added 80% so far this year. You can find these outstanding leadership issues with the IBD Stock Screener. X TG Therapeutics will sell Briumvi to health care providers …
Read More »Chipmaker Blasts Into Buy Zone On 700% Growth, IoT Expansion
GlobalFoundries (GFS) just beat Q4 estimates, propelling the contract GFS stock into a new buy zone. The breakout comes on the heels of the chipmaker forging a long-term agreement with General Motors (GM) and an acquisition to expand its IoT footprint. X The GM news and yet another explosive earnings …
Read More »Microsoft has a long path of earnings growth ahead, says Morgan Stanley
Microsoft Corp. has been a bit of an artificial-intelligence story lately, thanks to the company’s investment in and partnership with OpenAI, the creator of the hot ChatGPT chatbot. But Microsoft MSFT, +3.12% can also be an earnings-growth story, according to Morgan Stanley’s Keith Weiss. He wrote Monday that he models …
Read More »Attitudes begin to shift regarding monetary policy, economic growth, and stock prices
This post was originally published on TKer.co Stocks declined, with the S&P 500 falling 1.1% last week. The index is now up 6.5% year to date, up 14.4% from its October 12 closing low of 3,577.03, and down 14.7% from its January 3, 2022 closing high of 4,796.56. Over the …
Read More »